FDA revokes approval of Avastin for breast cancer
The Food and Drug Administration has declared the blockbuster drug Avastin should no longer be used in breast cancer patients because there's no proof it extends their lives - and it is causing dangerous side effects. Fri, 11/18/2011 - 5:58pm
Hearing may be end of road for breast cancer drug
The best-selling cancer drug in the world comes under federal scrutiny once again this week, as drugmaker Roche makes a last-ditch effort to keep its drug Avastin approved for breast cancer, despite evidence that it is ineffective against the disease. Mon, 06/27/2011 - 4:44pm